Key result
NSAID and aspirin use accounts for >40% of ulcer bleeding episodes and deaths in patients ≥60 years; substituting lower-risk NSAIDs and low-dose aspirin could reduce admissions from 4121 to <2184.
Why the study?
What is the annual burden of peptic ulcer bleeding and death associated with NSAID and aspirin use in patients aged 60 and over?
Observational
Yes
What is the annual burden of peptic ulcer bleeding and death associated with NSAID and aspirin use in patients aged 60 and over?
A substantial proportion of ulcer bleeding episodes and deaths in older adults are attributable to NSAIDs and aspirin, which could be markedly reduced by using lower-risk alternatives or lower doses.
May warrant preferential lower-risk NSAID/aspirin use in patients ≥60; extends observational burden estimates but leaves causal reduction open.
Information on the intake of non-steroidal anti-inflammatory drugs (NSAIDs) and on aspirin taken regularly by patients with peptic ulcer bleeding aged 60 years and over was used in conjunction with data measuring the overall frequency of hospital admissions with ulcer bleeding in England and Wales to determine the annual burden of disease imposed by particular treatment strategies. Over 40% of the calculated 8528 episodes of ulcer bleeding in those aged 60 years and over, and over 40% of the estimated 981 deaths each year would seem to be causally related to the treatments. Substitution of the NSAID with the lowest associated risk would be expected to reduce the frequency of non-aspirin NSAID-associated episodes of ulcer bleeding, and deaths, each by over 70%. Use of the lowest conventional dose of regular prophylactic aspirin (75 mg) would also be expected to reduce the frequency of treatment-related episodes, and deaths, by nearly 30%. Both strategies employed together would be expected to reduce NSAID and regular aspirin-related bleeding ulcer admissions from 4121 to less than 2184, and deaths from 523 to less than 250. Substitution of completely safe anti-inflammatory analgesics and anti-platelet drugs would be expected to reduce admissions from 4121 to 1072, and deaths from 523 to 123.
No takes yet. Share an insight, caveat, or question.
M. J. S. Langman (2001) conducted an observational in Peptic ulcer bleeding. NSAIDs and aspirin was evaluated on Hospital admissions with ulcer bleeding and deaths. NSAID and aspirin use accounts for >40% of ulcer bleeding episodes and deaths in patients ≥60 years; substituting lower-risk NSAIDs and low-dose aspirin could reduce admissions from 4121 to <2184.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: